Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative multidose tranexamic acid in total joint arthroplasty by fibrinolytic phenotype
ChiCTR2200057886Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in Bleeding (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Hidden blood loss, Decline of hemoglobin level and 3 more. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on ChiCTR2200057886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057886.